Concepedia

Daniel W. Sigelman

DW

Statistics

Publications

3

Citations

91

H-Index

3

Active since

2012

Affiliations

United States Food and Drug Administration(Current)

Daniel W. Sigelman is an author at United States Food and Drug Administration specializing in epidemiology, dementia, and neurodegeneration.

Top concepts

Publications per year

2012–2022

3

Publications

3

Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study

Peter Lurie, Harpreet Singh Chahal, Daniel W. Sigelman et al. · BMJ · 2015 · 36 citations · Full text

Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021

Andrea N. Monge, Daniel W. Sigelman, Robert J. Temple et al. · JAMA Network Open · 2022 · 29 citations · Full text

Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies

David Madigan, Daniel W. Sigelman, James W. Mayer et al. · American Heart Journal · 2012 · 26 citations

, , +11

1–3 of 3